Cargando…
Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment
Combination chemotherapy is a common clinical practice in cancer treatment. Here, cyclic RGD (arginylglycylaspartic acid) peptide was introduced to the surface of lipid/calcium/phosphate (LCP) asymmetric lipid layer nanoparticles for the co-delivery of paclitaxel (PTX) and gemcitabine monophosphate...
Autores principales: | Zhang, Jing, Zhang, Peng, Zou, Qian, Li, Xiang, Fu, Jianjiang, Luo, Ying, Liang, Xinli, Jin, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278289/ https://www.ncbi.nlm.nih.gov/pubmed/30405089 http://dx.doi.org/10.3390/molecules23112906 |
Ejemplares similares
-
cRGD peptide-conjugated polyethylenimine-based lipid nanoparticle for intracellular delivery of siRNA in hepatocarcinoma therapy
por: Yang, Shuang, et al.
Publicado: (2021) -
Enhanced Specificity and Drug Delivery in Tumors by cRGD - Anchoring Thermosensitive Liposomes
por: Dicheva, Bilyana M., et al.
Publicado: (2015) -
PAMAM-cRGD mediating efficient siRNA delivery to spermatogonial stem cells
por: Li, Tianjiao, et al.
Publicado: (2019) -
Enhanced Intercellular Delivery of cRGD–siRNA
Conjugates by an Additional Oligospermine Modification
por: Nakamoto, Kosuke, et al.
Publicado: (2018) -
Functional cRGD-Conjugated Polymer Prodrug for Targeted
Drug Delivery to Liver Cancer Cells
por: Zhou, Ru, et al.
Publicado: (2022)